A detailed history of Novem Group transactions in Pfizer Inc stock. As of the latest transaction made, Novem Group holds 15,612 shares of PFE stock, worth $387,958. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,612
Previous 15,330 1.84%
Holding current value
$387,958
Previous $388 Million 2.58%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 16, 2025

BUY
$21.59 - $24.84 $6,088 - $7,004
282 Added 1.84%
15,612 $378 Million
Q1 2025

Apr 28, 2025

BUY
$25.01 - $27.13 $26,610 - $28,866
1,064 Added 7.46%
15,330 $388 Million
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $353,796 - $430,690
14,266 New
14,266 $378 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Novem Group Portfolio

Follow Novem Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novem Group, based on Form 13F filings with the SEC.

News

Stay updated on Novem Group with notifications on news.